SR Spire Inc

The Standard Register Company (NYSE: SR) announced today that it has entered into a definitive agreement under which Standard Register will acquire 100% of the ownership interest in Dialog Medical, the leader in solutions for managing the patient informed consent process. Dialog Medical, which has approximately $5 million in annual revenue, will be operated as a wholly owned subsidiary of Standard Register and will report through Standard Register Healthcare. Terms of the transaction, which is expected to close by June 30, were not disclosed.

Standard Register Healthcare, a business unit of Standard Register, provides services and technology for patient identification verification, patient safety and streamlining workflow, serving more than 3,000 clients including 62 percent of U.S. hospitals. Dialog Medical, a privately held company headquartered in Atlanta, Ga., is the recognized leader in standardizing, automating and documenting the informed consent process. Its iMedConsent™ solution is used by 200 hospitals and approximately 15,000 physicians. iMedConsent™ is an application that physicians use to assist with educating and informing patients about conditions, diagnoses and treatments. It streamlines internal practices, standardizes communication across the enterprise and better documents informed consent encounters.

“This transaction is a good strategic fit; it strengthens and broadens our leadership in the healthcare market, and helps our customers advance their reputations by improving patient safety, compliance, critical patient communications and operational performance,” said Joseph P. Morgan, Jr., president and chief executive officer of Standard Register.

“Standard Register’s acquisition of Dialog Medical brings together two organizations with shared values and complementary lines of business. By leveraging the combined strength of both companies, we are building an even stronger healthcare business unit with scale, density and world-class products and services,” said Brad Cates, president of Standard Register Healthcare. “We are very excited to leverage the combined power of the new business to better serve our customers and innovate for the healthcare market.”

Standard Register Healthcare and Dialog Medical will continue to serve their respective customers as well as go to market with a combined portfolio of products and services. Dialog Medical, which employs 30 people, will continue to operate from its office in Atlanta, and will report to Brad Cates, president of Standard Register Healthcare.

“Together, Dialog Medical and Standard Register bring unmatched value to hospitals, physicians and other healthcare providers,” said Michael Burke, president of Dialog Medical. “Each has built a trusted leadership position, and we will capitalize upon each other’s distinct capabilities to positively impact patient safety and organizational efficiency.”

About Standard Register

Standard Register (NYSE: SR) is trusted by the world’s leading companies to advance their reputations by aligning their communications with corporate standards and priorities. Providing market-specific insights and a compelling portfolio of solutions to address the changing business landscape in commercial, healthcare and industrial markets, Standard Register is the recognized leader in the management and execution of mission-critical communications. More information is available at www.standardregister.com.

About Standard Register Healthcare

Standard Register Healthcare serves more than 3,100 hospitals and 100 of the nation's top integrated delivery networks (IDNs). It helps healthcare providers advance their reputations by accelerating performance, attracting and educating patients, enhancing patient safety, and improving the quality of care with document management and workflow automation solutions for patient identification and documentation, secure prescriptions, training, patient and marketing communications, as well as professional services and print supply chain services. More information is available at www.standardregister.com/healthcare.

About Dialog Medical

Dialog Medical is a leading provider of informed consent ant patient education systems for physician practices and hospitals. The company’s iMedConsent™ application is currently used by more than 15,000 physicians and in 200 hospitals and physician practices nationwide. For more information on Dialog Medical and its products, visit www.dialogmedical.com.

Safe Harbor statement

This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2011 and beyond could differ materially from the Company’s current expectations. Forward-looking statements are identified by words such as “anticipates,” “projects,” “expects,” “plans,” “intends,” “believes,” “estimates,” “targets,” and other similar expressions that indicate trends and future events.

Factors that could cause the Company’s results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company’s products and services, the frequency, magnitude and timing of paper and other raw-material-price changes, general business and economic conditions beyond the Company’s control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company’s success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information since these statements may no longer be accurate or timely.

Spire (NYSE:SR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Spire (NYSE:SR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024